Eyconis, Inc. is a privately held, pre-clinical stage biopharmaceutical company focused on transforming the ophthalmology treatment paradigm through the development, manufacture, and commercialization of novel, best-in-class therapeutics for eye diseases. The Company is advancing a pipeline of therapeutic candidates addressing areas of high unmet need including wet age-related macular degeneration (AMD). Eyconis is partnered with a syndicate of leading biopharma investors including Frazier Life Sciences, RA Capital Management, venBio Partners, and HealthQuest Capital. The Company is headquartered in Redwood City, California, including research & development laboratories with scientific and manufacturing team members.

Biotechnology

Life Sciences

Research

Therapeutics

Eyconis, Inc

Eyconis, Inc's headquarters in Redwood City, United States

Description

People (14)

Mark J. Bachleda

Yongqi Mu

David Hill

Jeffrey Aaronson

Tobias Friedberger

Nate Segraves

Christopher Chan

Yan Li

Christina Tsai

Oliver Stauch

Rolf Jansen

Nandini Anand

Chris Heynes

Bill Galush

Jobs